Breathe Well Live Well
|
Asthma Drug Rejected by UK's NICE
WebProNews The U.K.'s National Institute for Health and Clinical Excellence (NICE) this weekend issued a draft guidance stating that it does not recommend omalizumab, an asthma medication marketed as Xolair by Novartis Pharmaceuticals. NICE is a U.K. health … |
View full post on asthma – Google News
 CBC.ca |
Facebook link to asthma rejected by experts
Healthcare Republic Suggestions that Facebook-induced stress should be considered in accessing asthma attacks have been rejected by experts in the condition. … Can Facebook trigger asthma? Warning: Facebook can bring on asthma attack Health briefs |
View full post on asthma – Google News